Tricia Thornton-Wells
Company: Johnson & Johnson Services, Inc
Job title: Senior Director & Compound Development Team Leader
Seminars:
Novel Liposomal Active Immunotherapy Targeting pTau in Alzheimer’s Disease 4:00 pm
Introducing potentially pivotal phase 2b study testing JNJ-64042056 in A+T+ preclinical AD Early learnings and insights from precision medicine approach to pre-screening directly from diverse communities with pT217 Utilizing MOA-based precision neuroimaging measures to quantify spread of tau pathologyRead more
day: Conference Day Two PM